Founded in research from the University of Chicago, OrisDX has developed a novel non-invasive salivary diagnostic test utilizing biomarker-based molecular genomic techniques to diagnose oral cavity cancers earlier.
| Website | http://orisdx.com |
| Employees | 10 (5 on RocketReach) |
| Industry | Biotechnology |
| Keywords | Oral Cancer Screening, Early Cancer Detection, Non Invasive Diagnostics, Molecular Diagnostics, Cancer Screening, Genomic Diagnostics, Cancer Testing, Head And Neck Cancer, Diagnostic Testing, Molecular Testing, Liquid Biopsy, Oncology Diagnostics, Biomarker Discovery, Precision Oncology, Clinical Diagnostics |
| Competitors | Oracle Health Information, Epic, MEDITECH, Landin Ofshore, McKesson, athenahealth, NextGen Healthcare, eClinicalWorks, Greenway Health, EPILEPSY & BEHAVIOR NEUROLOGICAL SERVICES LLC +53 more (view full list) |
Looking for a particular OrisDX employee's phone or email?
Harald Steltzer is the CEO of OrisDX.
5 people are employed at OrisDX.
OrisDX is based in Chicago, Illinois.